Metabolomics Biomarkers for Precision Psychiatry

Area of Science:

• Psychiatry
• Metabolomics
• Biomarker Discovery

Background:

• Psychiatric disorders present diagnostic and treatment challenges due to heterogeneity.
• Current uniform treatment approaches yield limited success, necessitating precision medicine.

Purpose of the Study:

• To review the application of metabolomics in developing biomarkers for precision psychiatry.
• To summarize current metabolomic and lipidomic findings in psychiatric disorders, focusing on eicosanoids.

Main Methods:

• Review of current literature on clinical challenges in psychiatry.
• Overview of metabolomics as a tool for biomarker development.
• Summary of metabolomic and lipidomic studies in psychiatric disorders, emphasizing eicosanoids.

Main Results:

• Metabolomics offers insights into molecular pathology by detecting system-level metabolite alterations.
• Eicosanoids, involved in inflammation, are implicated in disorders like anorexia nervosa and depression.
• Metabolomics and lipidomics provide a promising avenue for identifying psychiatric disorder biomarkers.

Conclusions:

• Metabolomics is a valuable tool for advancing precision psychiatry.
• Further research in metabolomics can elucidate molecular mechanisms and improve diagnostic/therapeutic strategies.
• Precision psychiatry holds potential for discovering novel biomarkers and understanding underlying pathology.